Immune Abnormalities
Showing 1 - 25 of >10,000
Evaluation of Patients With Immune Function Abnormalities
Recruiting
- Chronic Granulomatous Disease (CGD)
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Cerebral Arterio-venous Malformation Trial in Limoges (Blood sample)
Recruiting
- Cerebral Arterio-venous Malformation
- Blood sample
-
Limoges, FranceLimoges University Hospital
Dec 23, 2022
Cancer, Immune-related Adverse Event, Cardiac Abnormalities, Variable Trial in Belgium (Cardiology consultation, Chest Computed
Recruiting
- Cancer
- +6 more
- Cardiology consultation
- +4 more
-
Deinze, East-Flanders, Belgium
- +3 more
Jan 26, 2023
Adverse Myocardial and Vascular Side Effects of Immune
Active, not recruiting
- Cancer
- +2 more
- Cardiac MRI
- +2 more
-
Paris, FranceAP-HP - Hôpital européen Georges-Pompidou
May 2, 2022
Respiratory System Abnormalities Trial in Al-Kharj (Manual Diaphragm Release, control group)
Completed
- Respiratory System Abnormalities
- Manual Diaphragm Release
- control group
-
Al-Kharj, Riyadh, Saudi ArabiaOutpatient Clinic of College of Applied Medical Sciences, Prince
Mar 27, 2023
Endocrine, Metabolic, Cardiovascular and Immunological Aspects
Recruiting
- Sex Chromosome Abnormality
- +5 more
- No intervention other than obtaining biopsies
-
Aarhus, Region Midt, DenmarkAarhus university hospital
Jun 20, 2022
Infectious Disease, Tumors, Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism
Recruiting
- Infectious Disease
- +20 more
-
Arlington Heights, IllinoisAnova Enterprises, Inc.
May 13, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +14 more
- radiation therapy
- +8 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell
No longer available
- Acute Lymphoblastic Leukemia
- +11 more
- CD34+ enriched, T Cell Depleted donor stem cell product
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 25, 2021
Pediatric Cancer Trial in Charlotte (Vaccine)
Recruiting
- Pediatric Cancer
- Vaccine
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 27, 2023
Disorders With Increased Susceptibility to Fungal Infections
Recruiting
- Fungal Infections
- Primary Immune Deficiencies
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Novel Genetic Disorders of the Immune System
Recruiting
- PI3KCD
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Common Variable Immunodeficiency and Related Syndromes
Recruiting
- CVID
- XLA
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Diabetes, Type 2, Obesity Trial in Edmonton (North American Diet)
Recruiting
- Diabetes Mellitus, Type 2
- Obesity
- North American Diet
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jan 11, 2023
Detection and Characterization of Host Defense Defects
Recruiting
- Immune Defects
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Normal Subjects and Disorders of Immune System and Cancer
Recruiting
- T-cell Lymphoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Immune Regulation in Ulcerative Colitis or Crohn s Disease
Recruiting
- Inflammatory Bowel Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Pulmonary Infection, COVID-19, Extracellular Matrix Alteration Trial in Surabaya (MMP-9 and TIMP-1)
Completed
- Pulmonary Infection
- +2 more
- MMP-9 and TIMP-1
-
Surabaya, East Java, IndonesiaUniversitas Airlangga Hospital
May 2, 2023
Neuron-specific Humoral and Cellular Immune Correlates of
Recruiting
- Systemic Lupus Erythematosus
- MRI
-
Milano, ItalyIRCCS Ospedale San Raffaele
May 18, 2023
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Sipuleucel-T Injection
- (no location specified)
Nov 10, 2023
Immune-mediated Diseases
Recruiting
- Primary Immunodeficiency
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2023
Ultrasound Trial in Sohag (ultrasound)
Not yet recruiting
- Ultrasound
- ultrasound
-
Sohag, EgyptSohag university hospital
May 3, 2023
Recurrent Unexplained Implantation Failure Trial (Certolizumab (CIMZIA® ; TNF-a antagonist), Placebo (NaCl 0.9 % solution))
Not yet recruiting
- Recurrent Unexplained Implantation Failure
- Certolizumab (CIMZIA® ; TNF-α antagonist)
- Placebo (NaCl 0.9 % solution)
- (no location specified)
Jun 30, 2023